Promising target candidate with multiple supporting evidence streams.
Automated synthesis of the evidence currently loaded. Review the underlying records before prioritizing this protein.
Main supporting evidence
Terms and data sources used on this page
PDB: experimentally determined structures from the Protein Data Bank. These are the strongest structural evidence, but may cover only part of the protein.
AlphaFold DB model: a precomputed predicted structure downloaded from AlphaFold Database/UniProt, not an experiment performed here.
ColabFold model: a predicted structure generated for this workspace; interpret it with coverage and confidence.
pLDDT: confidence score for predicted structures. High values support local geometry; low values mean the region should not drive pocket interpretation.
FPocket / P2Rank: software tools that predict possible ligand-binding pockets on a 3D structure. They are useful screening signals, not experimental validation.
Druggability: a pocket-based estimate of whether a small molecule could bind productively. It does not mean a drug already exists.
PDB ligand: a compound observed in an experimental structure. Direct same-protein records are stronger than homolog-transferred records.
ChEMBL: a public database of measured compound bioactivity. Direct entries are stronger than entries transferred from similar proteins.
ZINC: a purchasable-compound database. Here it marks proposed candidates from chemical similarity, not measured binders.
LigQ / LigQ_2: an internal Target pipeline step that gathers PDB, ChEMBL, and ZINC ligand evidence for each protein.
Off-target: sequence similarity to proteins we prefer not to hit, such as human proteins or beneficial gut microbiome proteins.
DEG: Database of Essential Genes. A match suggests the protein resembles genes known to be essential in other organisms.
Roary / CoreCruncher: pan-genome tools used to decide whether a gene is core across analyzed strains or accessory/strain-specific.
EC / GO: functional annotations: EC describes enzyme reactions; GO describes biological process, molecular function, or cellular component.
KEGG pathway: a curated metabolic route label used here to group reactions imported from the metabolic model.
Chokepoint: a metabolic reaction that is the only producer or consumer of a metabolite in the imported model.
Prioritization evidence
Selectivity, essentiality, structural confidence, conservation, and predicted binding-site evidence.
Off-target risk
- Human off-target
- No hit
- Gut microbiome similarity
- 2.3% of screened genomes Lower prevalence suggests narrower overlap with the screened gut microbiome.
Essentiality
- Essential (DEG)
- N
- DEG identity (%)
- 0.0 Higher values support similarity to known essential genes.
Structure confidence
- ColabFold pLDDT
- 89.58 0-100 confidence; >70 supports local structural interpretation.
Binding-site evidence
AlphaFold DB / UniProt modelP2Rank's binding-site probability is the primary druggability signal shown across the app; FPocket's druggability score is shown alongside it for comparison. Both estimate small-molecule pocket quality after applying the curated structure priority — neither is experimental binding evidence. The 3D viewer may show a different loaded structure, so visible pockets can differ.
Sequence
Primary amino-acid sequence viewer.
MALTAALKAQIAAWYKALQEQIPDFIPRPPQRQMIADVAKTLAGEEGRHLAIEAPTGVGKTLSYLIPGIAIAREEQKTLVVSTANVALQDQIYSKDLPLLRKIIPDLRFTAAFGRGRYVCPRNLTALASTEPSQQDLLAFLDDDLTPNNQAEQKLCATLKQDLDSYRWDGLRDHTDKAIDDGLWSRLSTDKASCLNRNCHYYRECPFFVARREIQEAEVVVANHALVMAAMESEAVLPEPKNLLLVLDEGHHLPDVARDALEMSAEITAPWFRLQLDLFCKLVATCMEQFRPKTTPPLANPERLTAHCEELFELIASLNNILNLYMPAGQEAEHRFPMGELPQEVMEICQRLAKLTELLRGLAELFLNDLSEKTGSHDVVRLHRVLLQMNRALGMFESQSKLWRLASLAQSSGAPVTKWATRVVRDGQIHVWFHCVGIRVSDQLERLLWRSVPHIVVTSATLRSLNSFSRLQEMSGLKEKAGDRFVALDSPFNHVEQGKIIIPQMRYEPLMDNEEQHIAEMAAYFRQQVESKKHLGMLVLFASGRAMNRFLEYVTDLRLMLLVQGDQPRYRLVELHRKRVESGERSVLVGLQSFAEGLDLKGDLLSQVHIHKIAFPPIDSPVVITEGEWLKSLNRYPFEVQSLPSASFNLIQQVGRLIRSHNCWGEVVIYDKRLLTKNYGARLLNALPVFPIEQPGVPEVIVKRKAKQTAKQTGRKRR
Functional annotations
Enzyme classification and Gene Ontology terms linked to this protein.
Subcellular localization
- Localization
- Cytoplasmic
Enzyme Commission (EC)
1Gene Ontology (GO)
14- GO:0004386 Catalysis of the reaction: ATP + H2O = ADP + phosphate, to drive the unwinding of a DNA or RNA helix.
- GO:0003676 Binding to a nucleic acid.
- GO:0003678 Unwinding of a DNA helix, driven by ATP hydrolysis.
- GO:0016818 Catalysis of the hydrolysis of any acid anhydride which contains phosphorus.
- GO:0006139 Any cellular metabolic process involving nucleobases, nucleosides, nucleotides and nucleic acids.
- GO:0005524 Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
- GO:0003677 Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid).
- GO:0051539 Binding to a 4 iron, 4 sulfur (4Fe-4S) cluster; this cluster consists of four iron atoms, with the inorganic sulfur atoms found between the irons and acting as bridging ligands.
- GO:0043139 Unwinding a DNA helix in the 5' to 3' direction, driven by ATP hydrolysis.
- GO:0016887 Catalysis of the reaction: ATP + H2O = ADP + H+ phosphate. ATP hydrolysis is used in some reactions as an energy source, for example to catalyze a reaction or drive transport against a concentration gradient.
- GO:0033677 Unwinding of a DNA/RNA duplex, i.e. a double helix in which a strand of DNA pairs with a complementary strand of RNA, driven by ATP hydrolysis.
- GO:0046872 Binding to a metal ion.
- GO:0006281 The process of restoring DNA after damage. Genomes are subject to damage by chemical and physical agents in the environment (e.g. UV and ionizing radiations, chemical mutagens, fungal and bacterial toxins, etc.) and by free radicals or alkylating agents endogenously generated in metabolism. DNA is also damaged because of errors during its replication. A variety of different DNA repair pathways have been reported that include direct reversal, base excision repair, nucleotide excision repair, photoreactivation, bypass, double-strand break repair pathway, and mismatch repair pathway.
- GO:0009432 An error-prone process for repairing damaged microbial DNA.
Sequence domains and features
Domain and signature matches imported from InterPro and related databases.
Show feature table
| Start | End | DB | Term | Name |
|---|---|---|---|---|
| 531 | 688 | Pfam | PF13307 | Helicase C-terminal domain |
| 531 | 688 | InterPro | IPR006555 | ATP-dependent helicase, C-terminal |
| 17 | 294 | ProSiteProfiles | PS51193 | Superfamilies 1 and 2 helicase ATP-binding type-2 domain profile. |
| 17 | 294 | InterPro | IPR014013 | Helicase superfamily 1/2, ATP-binding domain, DinG/Rad3-type |
| 26 | 277 | Gene3D | G3DSA:3.40.50.300 | - |
| 26 | 277 | InterPro | IPR027417 | P-loop containing nucleoside triphosphate hydrolase |
| 27 | 689 | PANTHER | PTHR11472 | DNA REPAIR DEAD HELICASE RAD3/XP-D SUBFAMILY MEMBER |
| 27 | 689 | InterPro | IPR045028 | Helicase superfamily 1/2, DinG/Rad3-like |
| 503 | 687 | FunFam | G3DSA:3.40.50.300:FF:000685 | ATP-dependent DNA helicase DinG |
| 27 | 287 | FunFam | G3DSA:3.40.50.300:FF:000700 | ATP-dependent DNA helicase DinG |
| 197 | 264 | Pfam | PF06733 | DEAD_2 |
| 197 | 264 | InterPro | IPR010614 | RAD3-like helicase, DEAD |
| 544 | 676 | SMART | SM00491 | Cxpdneu3 |
| 544 | 676 | InterPro | IPR006555 | ATP-dependent helicase, C-terminal |
| 34 | 695 | Hamap | MF_02205 | ATP-dependent DNA helicase DinG [dinG]. |
| 34 | 695 | InterPro | IPR039000 | ATP-dependent DNA helicase DinG |
| 504 | 687 | Gene3D | G3DSA:3.40.50.300 | - |
| 504 | 687 | InterPro | IPR027417 | P-loop containing nucleoside triphosphate hydrolase |
| 23 | 307 | SMART | SM00487 | ultradead3 |
| 23 | 307 | InterPro | IPR014001 | Helicase superfamily 1/2, ATP-binding domain |
| 31 | 94 | Pfam | PF00270 | DEAD/DEAH box helicase |
| 31 | 94 | InterPro | IPR011545 | DEAD/DEAH box helicase domain |
| 46 | 670 | SUPERFAMILY | SSF52540 | P-loop containing nucleoside triphosphate hydrolases |
| 46 | 670 | InterPro | IPR027417 | P-loop containing nucleoside triphosphate hydrolase |
| 18 | 294 | SMART | SM00488 | deadxpd |
| 18 | 294 | InterPro | IPR006554 | Helicase-like, DEXD box c2 type |
3D structure
Selected loaded structure. Experimental PDB entries may cover only a portion of the sequence; AlphaFold DB and ColabFold models typically cover the full protein but remain computational predictions.
How colors and pocket overlays are used
Pocket details Inspect a specific pocket, or open the full viewer
- Method
- -
- Score
- -
- Visible layer
- -
- Residues
- -
- Pocket properties
- -
Selecting a pocket opens its details and centers the viewer without clearing other active layers. Use Focus this pocket when you want to hide the rest; use Surface for the wider residue environment.
Binding pockets · P2Rank
Druggability (P2Rank): high ≥ 0.5 · medium 0.2–0.49 · low < 0.2
Binding pockets · FPocket
Druggability (FPocket): high ≥ 0.7 · medium 0.4–0.69 · low < 0.4
Residue sets
Binding pockets · P2Rank
Druggability (P2Rank): high ≥ 0.5 · medium 0.2–0.49 · low < 0.2
Binding pockets · FPocket
Druggability (FPocket): high ≥ 0.7 · medium 0.4–0.69 · low < 0.4
All structural evidence
Structural evidence
0 + 2Experimental PDB entries plus predicted AlphaFold DB or ColabFold models. Click Switch to display a different loaded structure in the viewer.
| Entry | Method | Resolution | Chain | Coverage | Links | Status |
|---|---|---|---|---|---|---|
|
AlphaFold DB
AF_A0A0H3GUG0
|
AlphaFold DB | — | — | full sequence | — | Viewing |
|
ColabFold
KP13_04320
|
ColabFold | — | — | full sequence | — | Loaded |
Ligand evidence
Ligands grouped by evidence source. PDB ligands keep the source crystal visible, and loaded crystals can be opened directly in the structure viewer.
Structural ligand evidence is available for this target.
Highest-confidence structural evidence: ligands co-crystallized with this exact protein. If the source PDB is loaded in Target, use Open crystal to inspect it in the structure viewer.
No PDB structure with a co-crystallized ligand found for this exact protein.
Structural evidence inferred from similar proteins. The source crystal indicates where the ligand was observed; the UniProt column identifies the homologous protein carrying that ligand.
Experimental bioactivity from ChEMBL measured directly on this protein. Score = pchembl (−log Ki/IC₅₀; higher = more potent).
No ChEMBL bioactivity data found for this exact protein.
Bioactivity inferred from similar proteins in ChEMBL. Score = pchembl (−log Ki/IC₅₀; higher = more potent).
No ChEMBL hits found through similar proteins.
Proposed virtual-screening candidates from ZINC. Score = Tanimoto similarity to a known binder (0–1; higher = more similar).
No virtual-screening candidates for this protein.
PDB and ChEMBL records on this protein are shown in full. ChEMBL records from similar proteins are capped at the top 100 per protein (by pchembl) and ZINC at the top 50 (Tanimoto ≥ 0.5). ADME columns are descriptor-based screening flags, not experimental toxicity results.
Cross-references
External database identifiers for this protein, its structures, ligands, and metabolic reactions.